Evidence map›Paper›PMID 40050325›Full record

ArticleScientific reports2025

Kleptomania on the impulsive-compulsive spectrum. Clinical and therapeutic considerations for women.

Lucero Munguía, Isabel Baenas-Soto, Roser Granero, Mar Fábregas-Balcells, Anahí Gaspar-Pérez, Magda Rosinska, Marc N Potenza, Ángel Cuquerella, Javier Tapia-Martínez, Rosa María Cabús-Grange and 5 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lucero MunguíaCIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain.
Isabel Baenas-SotoCIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain.
Roser GraneroCIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain.
Mar Fábregas-BalcellsDepartment of Clinical Psychology, University Hospital of Bellvitge, Feixa Llarga s/n, Hospitalet del Llobregat, 08907, Spain.
Anahí Gaspar-PérezDepartment of Clinical Psychology, University Hospital of Bellvitge, Feixa Llarga s/n, Hospitalet del Llobregat, 08907, Spain.
Magda RosinskaDepartment of Clinical Psychology, University Hospital of Bellvitge, Feixa Llarga s/n, Hospitalet del Llobregat, 08907, Spain.
Marc N PotenzaDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Ángel CuquerellaInstitute of Legal Medicine and Forensic Sciences of Catalonia, Barcelona, Spain.
Javier Tapia-MartínezPsychoneurobiology of Eating and Addictive Behaviors Group, Neurosciences Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Rosa María Cabús-GrangeInstitute of Legal Medicine and Forensic Sciences of Catalonia, Barcelona, Spain.
Ana María Taranilla-CastroInstitute of Legal Medicine and Forensic Sciences of Catalonia, Barcelona, Spain.
Marta Elisabet Macharé-AlberniInstitute of Legal Medicine and Forensic Sciences of Catalonia, Barcelona, Spain.
María Teresa Talón-NavarroInstitute of Legal Medicine and Forensic Sciences of Catalonia, Barcelona, Spain.
Fernando Fernández-ArandaCIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain. ffernandez@bellvitgehospital.cat.
Susana Jiménez-MurciaCIBER Fisiopatología Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Barcelona, Spain. sjimenez@bellvitgehospital.cat.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
AGAUR-Generalitat de Catalunya 2021-SGR-00824Catalan Institution for Research and Advanced Studies ICREA-Academia, 2021- ProgrammeDelegación del Gobierno para el Plan Nacional sobre Drogas 2021I031European Union's Horizon 2020 PRIME 847879Instituto de Salud Carlos III / European Social Fund. ESF investing in your future CM21/00172Instituto de Salud Carlos III (ISCIII) FIS PI20/00132Ministerio de Ciencia e Innovación PDI2021-124887OB-I00Ministerio de Ciencia e Innovación (Helps for predoctoral training contracts) PRE2022-104138NCATS NIH HHS UL1 TR001863Plan Nacional sobre Drogas Convocatoria de subvenciones para proyectos de investigación financiados con fondos europeos 2022 EXP2022/008847Union's Horizon 2020 eprObes 101080219
6 · The paper itself

Abstract

The current literature regarding kleptomania (KM) is scarce, especially regarding treatment approaches and outcomes. The aims of the present study involved: (1) exploring characteristics of people with KM (with and without co-occurring eating disorders (EDs)); (2) considering KM along an impulsive-compulsive spectrum; and, (3) investigating treatment outcomes in a clinical sample of female patients with KM. The study sample included 150 female participants with either a diagnosis of KM only (n = 13), co-occurring KM and EDs (n = 71), or healthy control individuals (HCs) (n = 66). The KM-only group was diagnosed using DSM-5 criteria and by a face-to-face clinical interviewed. EDs were diagnosed through a face-to-face semi-structured clinical interview based on DSM-5 criteria, and co-occurring KM was self-reported by patients. Psychopathology, impulsivity and personality features were assessed. Clinical groups received cognitive behavioral treatment. Compared to HCs, both KM groups reported more psychopathology, higher impulsivity, and more dysfunctional personality features. Relative to the clinical groups, that with KM + ED was more impulsive; in contrast, harm avoidance scores were higher in the KM-only group. Both clinical groups present poor treatment outcomes. KM can present impulsive and compulsive features, and these may impact treatment outcomes. Co-occurring KM and EDs may worsen clinical profiles and warrant specific interventions.

Indexed as

Disruptive, Impulse Control, and Conduct DisordersImpulsive BehaviorAdultCognitive Behavioral TherapyFeeding and Eating DisordersFemaleHumansMiddle AgedTreatment OutcomeYoung AdultCompulsive behaviorsEating disordersImpulsive behaviorsKleptomaniaTreatment outcome

Identifiers

PMID40050325
PMCPMC11885670

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.